Correlation Between Pfizer and 23291KAJ4
Specify exactly 2 symbols:
By analyzing existing cross correlation between Pfizer Inc and DH EUROPE FINANCE, you can compare the effects of market volatilities on Pfizer and 23291KAJ4 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of 23291KAJ4. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and 23291KAJ4.
Diversification Opportunities for Pfizer and 23291KAJ4
Poor diversification
The 3 months correlation between Pfizer and 23291KAJ4 is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and DH EUROPE FINANCE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DH EUROPE FINANCE and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with 23291KAJ4. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DH EUROPE FINANCE has no effect on the direction of Pfizer i.e., Pfizer and 23291KAJ4 go up and down completely randomly.
Pair Corralation between Pfizer and 23291KAJ4
Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the 23291KAJ4. In addition to that, Pfizer is 2.49 times more volatile than DH EUROPE FINANCE. It trades about -0.15 of its total potential returns per unit of risk. DH EUROPE FINANCE is currently generating about 0.17 per unit of volatility. If you would invest 7,947 in DH EUROPE FINANCE on September 4, 2024 and sell it today you would earn a total of 182.00 from holding DH EUROPE FINANCE or generate 2.29% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 95.24% |
Values | Daily Returns |
Pfizer Inc vs. DH EUROPE FINANCE
Performance |
Timeline |
Pfizer Inc |
DH EUROPE FINANCE |
Pfizer and 23291KAJ4 Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pfizer and 23291KAJ4
The main advantage of trading using opposite Pfizer and 23291KAJ4 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, 23291KAJ4 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 23291KAJ4 will offset losses from the drop in 23291KAJ4's long position.Pfizer vs. Crinetics Pharmaceuticals | Pfizer vs. Enanta Pharmaceuticals | Pfizer vs. Amicus Therapeutics | Pfizer vs. Connect Biopharma Holdings |
23291KAJ4 vs. Marfrig Global Foods | 23291KAJ4 vs. Datadog | 23291KAJ4 vs. Tyson Foods | 23291KAJ4 vs. Kaltura |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |